A STUDY OF NEUTROPHIL LYMPHOCYTE-TO-ALBUMIN RATIO TO PREDICT SHORT-TERM MORTALITY IN ALCOHOL-RELATED LIVER DISEASE
DOI:
https://doi.org/10.22159/ajpcr.2024v17i8.52197Keywords:
Neutrophil lymphocyte-to-albumin ratio, Alcoholic liver disease, Cirrhosis, MortalityAbstract
Objectives: The aims of this study were as follows: (1) to study neutrophil lymphocyte-to-albumin ratio (NLAR) in alcohol-related liver disease patients to predict 30-day mortality and (2) to determine the optimal cutoff value of the NLAR that maximizes sensitivity and specificity for predicting short-term mortality.
Methods: A prospective study conducted at our hospital for 18 months. A total of 46 males visiting the medicine OPD and IPD were included in the study. Blood samples were collected to measure neutrophil, lymphocyte, albumin levels were measured using standard methods. Data were analyzed using appropriate inferential statistics
Results: The majority of participants fall within the 31–40 age group (26.1%), followed by the 41–50 age group (23.9%). The majority of participants were diagnosed with cirrhosis of the liver (65.2%), while alcoholic hepatitis (AH) and fatty liver disease were both observed in 17.4% of the participants. The outcomes at 30 days a significant majority of the cases resulted in death (65.2%), with only 34.8% of the cases being followed up. We observe that for NLA, the cutoff value is observed to be 19.15 with a sensitivity of 100% and specificity of 100%. There is a significant mean difference observed for Hemoglobin, total count, neutrophil, lymphocyte, urea, INR, total protein, albumin, and NLA.
Conclusion: A cutoff value of 19.15 for the NLAR is identified as highly sensitive and specific, highlighting its clinical significance as patients with an NLA ratio above this threshold have a high probability of death within 30 days.
Downloads
References
Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG clinical guideline: Alcoholic liver disease. Am J Gastroenterol. 2018 Feb;113(2):175-94. doi: 10.1038/ajg.2017.469, PMID 29336434
Fuster D, Samet JH. Alcohol use in patients with chronic liver disease. N Engl J Med. 2018;379(13):1251-61. doi: 10.1056/NEJMra1715733, PMID 30257164
Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SM, et al. Liver diseases in the Asia-Pacific region: A Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2020;5(2):167-228. doi: 10.1016/S2468-1253(19)30342-5, PMID 31852635
Sauerbruch T, Schierwagen R, Trebicka J. Managing portal hypertension in patients with liver cirrhosis. F1000Res. 2018 May 2;7:F1000 Faculty Rev-533. doi: 10.12688/f1000research.13943.1, PMID 29780579, PMC5934688
Siddique A, Kowdley KV. Approach to a patient with elevated serum alkaline phosphatase. Clin Liver Dis. 2012 May;16(2):199-229. doi: 10.1016/j.cld.2012.03.012, PMID 22541695, PMC3341633
Trebicka J, Garcia-Tsao G. Controversies regarding albumin therapy in cirrhosis. Hepatology. 2023 Aug doi: 10.1097/ HEP.0000000000000521, PMID 37540192
Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122(7):474-88. doi: 10.4149/ BLL_2021_078, PMID 34161115
Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: Pathogenesis and clinical significance. J Parenter Enter Nutr. 2019 Feb;43(2):181-93. doi: 10.1002/jpen.1451, PMID 30288759, PMC7379941
Mitchell MC, Cotter TG. Unraveling the roles of excessive alcohol use and liver disease in mortality. Alcohol Clin Exp Res (Hoboken). 2023 Mar;47(3):429-31. doi: 10.1111/acer.15007, PMID 36585252, PMC10050149
Jeong JH, Lee SB, Sung A, Shin H, Kim DH. Factors predicting mortality in patients with alcoholic liver cirrhosis visiting the emergency department. Medicine (Baltimore). 2023;102(8):e33074. doi: 10.1097/ MD.0000000000033074, PMID 36827072
Orrego H, Israel Y, Blake JE, Medline A. Assessment of prognostic factors in alcoholic liver disease: Toward a global quantitative expression of severity. Hepatology. 1983 Nov-Dec;3(6):896-905.doi: 10.1002/hep.1840030602, PMID 6629318
Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoy Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut. 2005 Aug;54(8):1174-9. doi: 10.1136/gut.2004.050781, PMID 16009691, PMC1774903
Zhang M, Zhang Y, Liu L, Prithweeraj M, Xu H, Wu R, et al. Neutrophil-to-lymphocyte ratio and albumin: New serum biomarkers to predict the prognosis of male alcoholic cirrhosis patients. BioMed Res Int. 2020 Dec 21;2020:7268459. doi: 10.1155/2020/7268459, PMID 33415154, PMC7769654
Du X, Wei X, Ma L, Liu X, Guo H, Liu Y, et al. Higher levels of neutrophil percentage-to-albumin ratio predict increased mortality risk in patients with liver cirrhosis: A retrospective cohort study. Eur J Gastroenterol Hepatol. 2023 Feb;35(2):198-203. doi: 10.1097/ MEG.0000000000002470, PMID 36472501
Abu Omar Y, Randhawa T, Attar B, Agrawal R, Wang Y, Pichardo R, et al. Prognostic value of neutrophil-lymphocyte ratio in patients with severe alcoholic hepatitis. Cureus. 2019;11(11):e6141. doi: 10.7759/ cureus.6141, PMID 31886076
Published
How to Cite
Issue
Section
Copyright (c) 2024 SACHIN PATIL, KOTLI NAGARAJ, NIVEDITA M TAYAMGOL, HEMANTH REDDY NUKALA
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
